[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6711 Introduced in House (IH)]

<DOC>






117th CONGRESS
  2d Session
                                H. R. 6711

 To prohibition Federal spending on funding research in China, and for 
                            other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 11, 2022

   Ms. Herrell (for herself, Mr. Banks, Mr. McKinley, Mr. Hern, Mrs. 
 Miller of Illinois, Mr. Higgins of Louisiana, Mr. Reschenthaler, Mr. 
  Austin Scott of Georgia, Mr. Donalds, Mr. Cawthorn, Mr. Norman, Mr. 
  Posey, Mr. Hudson, and Mrs. Cammack) introduced the following bill; 
 which was referred to the Committee on Science, Space, and Technology

_______________________________________________________________________

                                 A BILL


 
 To prohibition Federal spending on funding research in China, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop Funding Our Adversaries Act of 
2022''.

SEC. 2. PROHIBITION ON FUNDING RESEARCH IN CHINA.

    The Secretary of Defense, the Secretary of Veterans Affairs, the 
Secretary of Energy, the Administrator of the Environmental Protection 
Agency, the Secretary of the Interior, the Secretary of Transportation, 
the Secretary of Health and Human Services, or any other Federal agency 
may not directly or indirectly conduct or support, through grants, 
subgrants, contracts, cooperative agreements or other funding vehicles, 
research that will be conducted by--
            (1) the Government of the People's Republic of China or any 
        agent or instrumentality of the Government of the People's 
        Republic of China or any entity owned by or controlled by the 
        People's Republic of China; or
            (2) the Chinese Communist Party or any agent or 
        instrumentality of Chinese Communist Party or any entity owned 
        by or controlled by the Chinese Communist Party.
                                 <all>